top of page

Search


Your Medicine, Made Just for You: The future of 3D Printed Drugs.
Think of a day when your medicine is not a bland tablet but rather something which can be printed within no time since you have the to the pharmacy. In the world of today, this is indeed possible. It is called 3D printing of medicines and it may change the very way we produce and use drugs. To appreciate the implications of this technology, pharmacy students note that it integrates the pharmaceutical sciences, engineering, and innovation in healthcare. And so, we will tackle
ACS BCP
6 days ago5 min read


Tiny Glues with Huge Impact: Are Molecular Glues Nature’s Secret Engineers?
Molecular glues are monovalent small molecules, typically weighing less than 500 daltons, that change the surface of one protein, usually an E3 ligase receptor, in order to recruit another protein, known as a neosubstrate which aids in induction of the novel protein-protein interactions. It is a breakthrough within the field of Targeted Protein Degradation (TPD), a therapeutic approach that aims to destroy the unwanted or misfolded proteins responsible for causing various dis
ACS BCP
6 days ago5 min read


Understanding the Incurable: Investigating Rabies and the Science Behind Its Evolving Therapies
Introduction- A recent case of 28th June 2025 in India of a 22-year-old State gold medallist kabaddi player Brijesh Solanki who wasn’t vaccinated after a Dog bite, passed away due to Acute Neurological Stage of Rabies. On 11th August 2025, the Delhi Supreme Court issued a mandate of capturing and relocation of stray dogs from Delhi-NCR Streets to shelters due to increasing number of dog bite cases with fatal consequences due to rabies, later on similar actions were taken by t
ACS BCP
6 days ago5 min read


PROTACs: The Game-Changers in our Fight Against Cancer
PROTACs: The Game-Changers in our Fight Against Cancer Think of a new type of medicine that not only blocks a disease-causing protein but also completely eliminates it from the body. This is not a science fiction; it is the revolutionary promise of PROTACs (Proteolysis-Targeting Chimeras), an exciting new class of drugs assured to redefine cancer treatment and other incapacitating diseases. PROTACs are like a tiny molecular matchmakers or a bridge where one end of this bridge
ACS BCP
6 days ago3 min read


MAVACAMTEN: First and only cardiac myosin inhibitor
1. Introduction Mavacamten, marketed under the brand name Camzyos, is a first-in-class cardiac myosin inhibitor developed by Bristol...
ACS BCP
May 25, 20253 min read
bottom of page
